Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogen pens open letter to Alzheimer’s community

July 23, 2021
Medical Communications

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …

News

Parents warned as child respiratory illness on the rise this summer

July 23, 2021
Medical Communications

Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …

News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …

News

Bayer/MSD heart failure drug gains EC approval

July 22, 2021

The European Commission (EC) has approved MSD and Bayer’s Verquvo (vericiguat) for the treatment of symptomatic chronic heart failure in …

News

China rejects a second WHO probe into COVID outbreak origin

July 22, 2021
COVID-19, China

China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …

News
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

News

NICE approves treatment for rare bile duct cancer

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …

News
catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021
Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …

News

Former FDA adviser calls for further investigation into Alzheimer’s drug

July 21, 2021
Research and Development

A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …

News

Exscientia and Apeiron announce joint oncology venture

July 21, 2021
Research and Development

AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …

News

J&J ‘one shot’ vaccine ineffective against Delta variant, study finds

July 21, 2021
Medical Communications, Research and Development

A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …

News

More than 13,000 women report period changes after COVID vaccine

July 21, 2021
Research and Development COVID, Vaccine, menstruation, periods

The number of women who have reported changes to their period to the MHRA after having the COVID vaccine has …

News
andrei_r_-_shutterstock_1935537274_720

Bial and Medis to enter partnership on CNS treatments

July 20, 2021
Manufacturing and Production, Sales and Marketing

BIAL and Medis have entered into an exclusive partnership on two of Bial’s proprietary drugs: its Parkinson’s treatment Ongentys (opicapone) …

News

60% of UK COVID-19 hospital admissions are unvaccinated people

July 20, 2021
Manufacturing and Production

The Government’s Chief Scientific Adviser Sir Patrick Vallance has said that 60% of people being admitted to hospital with COVID-19 …

News

$26 billion opioid settlement to be unveiled this week in US

July 20, 2021
Manufacturing and Production, Research and Development, Sales and Marketing

US state attorneys general are set to unveil a $26 billion settlement this week, aimed at three major drug distributors …

News

Blood biomarker discovered that can predict COVID-19 infection

July 20, 2021
Manufacturing and Production, Research and Development COVID-19. blood testing, biomarker, gene

Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping …

News

Brits unable to order lateral flow tests on ‘Freedom Day’

July 20, 2021
Manufacturing and Production

Brits were temporarily unable to order lateral flow COVID-19 test kits on ‘Freedom Day’, the day nearly all restrictions in …

News
astrazeneca_plaque_web

AstraZeneca’s lung cancer drug Imfinzi approved in China

July 19, 2021
Sales and Marketing

China has approved AstraZeneca’s drug Imfinzi to treat an aggressive type of lung cancer in adults. The drug’s use with …

News

Medical cannabis formulation kills prostate cancer in laboratory tests

July 19, 2021
Sales and Marketing medical cannabis, prostate cancer

Apollon Formularies have announced its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate …

News
mufid-majnun-oi20ehignd4-unsplash

Long COVID: 15 studies launched with £19.6 million government funding

July 19, 2021
Sales and Marketing NHS, UK, long covid

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026